Patricia Sorni

Palma, PM 07198, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

CABO-CHANCE study: A real-life world study of Cabotegravir plus Rilpivirine long-acting intramuscular in ART-experienced people with HIV.

CABO-CHANCE study: A real-life world study of Cabotegravir plus Rilpivirine long-acting intramuscular in ART-experienced people with HIV.

Journal: International journal of antimicrobial agents

Published: April 27, 2026

Correction: Impact of bictegravir/emtricitabine/tenofovir alafenamide on health-related quality of life and economic outcomes in HIV care: Substudy of the BIC-NOW clinical trial.

Correction: Impact of bictegravir/emtricitabine/tenofovir alafenamide on health-related quality of life and economic outcomes in HIV care: Substudy of the BIC-NOW clinical trial.

Journal: PloS one

Published: January 20, 2026

Impact of bacterial sexually transmitted infections on human papillomavirus and anal dysplasia in people living with HIV.

Impact of bacterial sexually transmitted infections on human papillomavirus and anal dysplasia in people living with HIV.

Journal: Scientific reports

Published: December 12, 2025

The Role of Human Papillomavirus Genotypes on Anal Squamous Intraepithelial Lesions Among Gay, Bisexual and Other Men Who Have Sex With Men Living With HIV: Beyond HPV-16.

The Role of Human Papillomavirus Genotypes on Anal Squamous Intraepithelial Lesions Among Gay, Bisexual and Other Men Who Have Sex With Men Living With HIV: Beyond HPV-16.

Journal: Journal of medical virology

Published: June 06, 2025

Impact of bictegravir/emtricitabine/tenofovir alafenamide on health-related quality of life and economic outcomes in HIV care: Substudy of the BIC-NOW clinical trial.

Impact of bictegravir/emtricitabine/tenofovir alafenamide on health-related quality of life and economic outcomes in HIV care: Substudy of the BIC-NOW clinical trial.

Journal: PloS one

Published: November 11, 2024

Identifying risk factors for anal cancer in people with HIV in Spain: a multicentre retrospective cohort study nested in the PISCIS cohort.

Identifying risk factors for anal cancer in people with HIV in Spain: a multicentre retrospective cohort study nested in the PISCIS cohort.

Journal: The lancet. HIV

Published: February 24, 2024

Bictegravir/emtricitabine/tenofovir alafenamide as first-line treatment in naïve HIV patients in a rapid-initiation model of care: BIC-NOW clinical trial.

Bictegravir/emtricitabine/tenofovir alafenamide as first-line treatment in naïve HIV patients in a rapid-initiation model of care: BIC-NOW clinical trial.

Journal: International journal of antimicrobial agents

Published: January 22, 2024

Factors associated with SARS-CoV-2 infection among people living with HIV: Data from the Balearic cohort (EVHIA).

Factors associated with SARS-CoV-2 infection among people living with HIV: Data from the Balearic cohort (EVHIA).

Journal: PloS one

Published: January 10, 2024

Showing 1-8 of 8

Last Updated: 09/26/2026